Myriad Genetics Inc.

NASDAQ: MYGN · Real-Time Price · USD
5.71
-0.18 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
5.66
-0.96%
After-hours: Aug 15, 2025, 05:30 PM EDT

Myriad Genetics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-9.76 -6.02 -10.44 -78.86
PEG Ratio
0.18 -0.05 -0.04 0.89
PS Ratio
1.48 2.10 1.72 3.11
PB Ratio
1.77 2.02 1.32 2.22
P/FCF Ratio
-32.35 -8.6 -7.71 3.57K
P/OCF Ratio
-142.77 -14.29 -11 115.32
OCF/S Ratio
-0.01 -0.15 -0.16 0.03
Debt / Equity Ratio
0.20 0.19 0.16 0.10
Quick Ratio
1.65 1.87 1.85 2.30
Current Ratio
1.82 2.01 2.00 2.37
Asset Turnover
0.82 0.66 0.57 0.52
Interest Coverage
-44.11 -88.76 -38.66 -7.38
Return on Equity
-0.18 -0.34 -0.13 -0.03
Return on Assets
-0.12 -0.23 -0.09 -0.02
Return on Invested Capital
-0.15 -0.26 -0.09 -0.02
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.70 0.69 0.70 0.71
Net Profit Margin
-0.15 -0.35 -0.17 -0.04
Pretax Profit Margin
-0.15 -0.35 -0.21 -0.08
Operating Profit Margin
-0.15 -0.34 -0.18 -0.07
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.07 -0.25 -0.1 0.02